Lior Lupu

503 total citations
48 papers, 231 citations indexed

About

Lior Lupu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lior Lupu has authored 48 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lior Lupu's work include Acute Myocardial Infarction Research (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Coronary Interventions and Diagnostics (8 papers). Lior Lupu is often cited by papers focused on Acute Myocardial Infarction Research (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Coronary Interventions and Diagnostics (8 papers). Lior Lupu collaborates with scholars based in Israel, United States and Spain. Lior Lupu's co-authors include Shmuel Banai, Ariel Banai, Aviram Hochstadt, Yacov Shacham, Philippe Taieb, Orly Sapir, Yael Lichter, Michal Laufer‐Perl, Yoav Granot and Yishay Szekely and has published in prestigious journals such as Journal of the American College of Cardiology, Scientific Reports and The American Journal of Medicine.

In The Last Decade

Lior Lupu

38 papers receiving 229 citations

Peers

Lior Lupu
Lior Lupu
Citations per year, relative to Lior Lupu Lior Lupu (= 1×) peers Valeria Donghi

Countries citing papers authored by Lior Lupu

Since Specialization
Citations

This map shows the geographic impact of Lior Lupu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lior Lupu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lior Lupu more than expected).

Fields of papers citing papers by Lior Lupu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lior Lupu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lior Lupu. The network helps show where Lior Lupu may publish in the future.

Co-authorship network of co-authors of Lior Lupu

This figure shows the co-authorship network connecting the top 25 collaborators of Lior Lupu. A scholar is included among the top collaborators of Lior Lupu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lior Lupu. Lior Lupu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haberman, Dan, Lior Lupu, Kalyan R. Chitturi, et al.. (2025). Percutaneous Management of Vessel Occlusion Caused by Suture‐Based Closure Devices: A Case Series and Benchtop Model. Catheterization and Cardiovascular Interventions. 106(2). 1078–1087. 1 indexed citations
2.
Abusnina, Waiel, Kalyan R. Chitturi, Lior Lupu, et al.. (2025). Gender disparities in cangrelor usage for the treatment of patients with acute coronary syndrome undergoing percutaneous coronary intervention. International Journal of Cardiology. 432. 133280–133280. 1 indexed citations
3.
Lupu, Lior, Gregg W. Stone, Ramesh Daggubati, et al.. (2025). Beyond the guidelines: expert perspectives on the management of AMI-related cardiogenic shock from the Cardiovascular Research Technologies (CRT) 2025 meeting. Cardiovascular revascularization medicine. 75. 3–7.
4.
Lupu, Lior, Dan Haberman, Cheng Zhang, et al.. (2025). Decision-making in valve reintervention: Redo—Transcatheter aortic valve replacement vs. explant surgery. Cardiovascular revascularization medicine.
5.
Verma, Beni, Dan Haberman, Cheng Zhang, et al.. (2025). Safety of pre-procedure fasting versus non-fasting protocols before cardiac catheterization – a Bayesian meta-analysis of randomized clinical trials. Cardiovascular revascularization medicine.
6.
Abusnina, Waiel, Kalyan R. Chitturi, Lior Lupu, et al.. (2025). Lack of Racial Disparities in Cangrelor Therapy in Patients Presenting With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. 105(5). 1188–1195. 1 indexed citations
7.
Abusnina, Waiel, Kalyan R. Chitturi, Beni Verma, et al.. (2025). 100.25 Impact of Cangrelor on Patients With Acute Myocardial Infarction-Induced Cardiogenic Shock Undergoing Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 18(4). S32–S32. 1 indexed citations
8.
Lupu, Lior, et al.. (2025). Valve-Leaflet Interaction During UNICORN in Redo-TAVR. JACC: Cardiovascular Interventions. 18(16). 2059–2061.
9.
Chitturi, Kalyan R., Abhishek Chaturvedi, Lior Lupu, et al.. (2025). Examining the relationship between monocytes and monocyte-derived ratios in post-percutaneous coronary intervention patients and their impact on coronary artery disease progression. Cardiovascular revascularization medicine. 81. 5–10.
10.
Chitturi, Kalyan R., Cheng Zhang, Waiel Abusnina, et al.. (2024). High-risk percutaneous coronary intervention with or without mechanical circulatory support: Will Impella show superiority in the PROTECT IV randomized trial?. Cardiovascular revascularization medicine. 73. 59–63. 1 indexed citations
11.
Chitturi, Kalyan R., Avantika Banerjee, Abhishek Chaturvedi, et al.. (2024). Bioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art Review. Circulation Cardiovascular Interventions. 17(7). e014143–e014143. 3 indexed citations
12.
Lupu, Lior, et al.. (2024). Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system. American Heart Journal. 275. 21–34. 1 indexed citations
13.
Chorin, Ehud, Rachel Lampert, Nick R. Bijsterveld, et al.. (2024). Safety of Sports for Patients with Subcutaneous Implantable Cardioverter Defibrillator (SPORT S-ICD): study rationale and protocol. Heart Rhythm O2. 5(3). 182–188. 2 indexed citations
14.
Hochstadt, Aviram, Ilan Merdler, Yishay Szekely, et al.. (2023). Clustering of clinical and echocardiographic phenotypes of covid-19 patients. Scientific Reports. 13(1). 8832–8832. 2 indexed citations
15.
Lupu, Lior, et al.. (2022). Artificial Intelligence-Based Stethoscope for the Diagnosis of Aortic Stenosis. The American Journal of Medicine. 135(9). 1124–1133. 24 indexed citations
16.
17.
Lupu, Lior, Ariel Banai, Yishay Szekely, et al.. (2022). The added predictive role of echocardiography in patients with mild or moderate Coronavirus Disease 2019. International Journal of Cardiology. 371. 492–499. 1 indexed citations
18.
Havakuk, Ofer, Aviram Hochstadt, Ben Sadeh, et al.. (2022). Successful Conservative Management of Left Ventricular Assist Device Candidates. ESC Heart Failure. 10(1). 601–615. 1 indexed citations
19.
Banai, Ariel, Yishay Szekely, Lior Lupu, et al.. (2022). QT Interval Prolongation Is a Novel Predictor of 1-Year Mortality in Patients With COVID-19 Infection. Frontiers in Cardiovascular Medicine. 9. 869089–869089. 5 indexed citations
20.
Szekely, Yishay, Yael Lichter, Lior Lupu, et al.. (2021). Cardiorespiratory Abnormalities in Patients Recovering from Coronavirus Disease 2019. Journal of the American Society of Echocardiography. 34(12). 1273–1284.e9. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026